Human malignant hyperthermia: awake episodes and correction by dantrolene.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D002110:Caffeine / Q000494:pharmacology; D003620:Dantrolene / Q000627:therapeutic use*; D005221:Fatigue / Q000150:complications*; D005260:Female; D006221:Halothane / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008305:Malignant Hyperthermia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000378:metabolism; D013312:Stress, Physiological / Q000150:complications*; D014851:Wakefulness
D002110:Caffeine; D000255:Adenosine Triphosphate; D003620:Dantrolene; D006221:Halothane